Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2985 (LINC02985) is a member of the long non-coding RNA (lncRNA) family, located in an intergenic region of the human genome[1][5]. LINC02985 does not encode a protein and functions primarily by regulating the expression of other genes, often at the level of chromatin structure, RNA stability, or by acting as molecular scaffolds[1][2]. Recent research suggests that LINC02985, alongside other lncRNAs, may be involved in modulating the immune microenvironment and cancer progression, serving as part of multivariate risk models for patient prognosis, especially in gastric cancer[2]. However, the precise biological functions and molecular mechanisms of LINC02985 require further investigation. As of now, it is not a classical drug target, nor are there drugs that directly modulate its activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2985 (LINC02985).